共 50 条
- [31] Pharmacokinetic Drug-Drug Interaction With Coadministration of Cannabidiol and Everolimus in a Phase 1 Healthy Volunteer Trial [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, : 911 - 919
- [32] A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (08): : 1009 - 1031
- [36] DRUG-DRUG INTERACTION STUDY BETWEEN ZAMICASTAT AND WARFARIN IN HEALTHY SUBJECTS [J]. CHEST, 2020, 158 (04) : 2271A - 2271A
- [38] Effect of Multiple Doses of Sparsentan on the Single-Dose Pharmacokinetics of Dapagliflozin: An Open-Label Drug-Drug Interaction Study in Healthy Adults [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (05): : 535 - 541
- [39] An open-label study to explore the optimal design of CYP3A drug-drug interaction clinical trials in healthy Chinese people [J]. PHARMACOLOGY RESEARCH & PERSPECTIVES, 2024, 12 (04):
- [40] DRUG-DRUG INTERACTION STUDY BETWEEN ZAMICASTAT AND BOSENTAN IN HEALTHY SUBJECTS [J]. CHEST, 2020, 157 (06) : 382A - 382A